Copyright
©The Author(s) 2025.
World J Gastrointest Surg. Mar 27, 2025; 17(3): 100951
Published online Mar 27, 2025. doi: 10.4240/wjgs.v17.i3.100951
Published online Mar 27, 2025. doi: 10.4240/wjgs.v17.i3.100951
Figure 3 Timeline of treatment.
After four courses of the hepatic arterial infusion chemotherapy regimen, lenvatinib and tislelizumab were canceled, preparing for surgery. Multiple metastatic sites were found in the lung on February 27, 2023. HAIC: Hepatic arterial infusion chemotherapy; TACE: Transcatheter arterial chemoembolization.
- Citation: Wang CD, Liu RD, Liu MJ, Song J. Lung metastasis following temporary discontinuation of lenvatinib and tislelizumab in hepatocellular carcinoma: A case report. World J Gastrointest Surg 2025; 17(3): 100951
- URL: https://www.wjgnet.com/1948-9366/full/v17/i3/100951.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i3.100951